Filing metadata

Accession number
0001209191-23-059324
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Dec 20, 2023
Reporting period
Dec 18, 2023
Description
Insider transaction

Explore SEC Filings Hub